Patient Centricity
Search documents
Daiichi Sankyo Company (OTCPK:DSKY.F) 2025 Earnings Call Presentation
2025-11-28 06:30
Some of the compounds under discussion are investigational agents and are not approved by the FDA or any other regulatory agency worldwide as a treatment for indications under investigation. Efficacy and safety have not been established in areas under investigation. There are no guarantee that these compounds will become commercially available in indications under investigation. Daiichi Sankyo takes reasonable care to ensure the accuracy of the content of this material, but shall not be obliged to guarantee ...